Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
55 hedge funds and large institutions have $143M invested in Derma Sciences, Inc. Common Stock (DE) in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
6% more funds holding
Funds holding: 52 → 55 (+3)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
15% less capital invested
Capital invested by funds: $168M → $143M (-$24.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$4.06M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$1.68M |
| 3 |
BC
Broadfin Capital
New York
|
+$1.16M |
| 4 |
Bank of New York Mellon
New York
|
+$854K |
| 5 |
RA
Royce & Associates
New York
|
+$639K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$6.83M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$5.26M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.25M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$193K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$174K |
DSCI Hedge Fund Activity: Q4 2013 in Review
55 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q4 2013, worth a combined $143M — down 15% from $168M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DSCI positions and 6 closed out — a net gain of 4 holders — while 15 added to existing stakes and 14 trimmed.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $4.06M. The largest seller was Raging Capital Management, cutting an estimated $6.83M.
- 55 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q4 2013, up from 52 in Q3 2013.
- Funds reported $143M of Derma Sciences, Inc. Common Stock (DE) stock for Q4 2013, down 15% quarter-over-quarter.
- 10 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q4 2013 and 6 closed out, a net change of +4 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q4 2013 was Manulife (Manufacturers Life Insurance), an estimated $4.06M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q4 2013 was Raging Capital Management, an estimated $6.83M sold.
Based on aggregated 13F filings for Q4 2013.